Abstract
Purpose
Despite improved anti-neoplastic treatment the prognosis for patients with liver metastases from metastatic breast cancer remains poor.
Materials and methods
Thirty-two consecutive patients with metastatic breast cancer treated with radiofrequency ablation (RFA) at the Department of Oncology, Herlev Hospital, University of Copenhagen, from 1996 to 2010.
Results
Time to intrahepatic progression was median 11 months (range 1.6–184 months). Median survival after first RFA was 33.5 months. Survival at 1, 2 and 3 years was 87, 68 and 48 %, respectively. The local recurrence rate was 22 %.
Conclusions
In this small, highly selected cohort we found RFA safe and efficacious with a low local recurrence rate and a median survival above that expected with systemic treatment. Our data are in line with previous studies and underscore the need for a large prospective study using optimal chemotherapy regimens and RFA/surgery to clarify whether intense treatment protocols can prolong survival for certain patient groups.
Similar content being viewed by others
References
Insa A, Lluch A, Prosper F et al (1999) Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 56:67–78
Atalay G, Biganzoli L, Renard F et al (2003) Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. Eur J Cancer 39:2439–2449
Kuru B, Camlibel M, Dinc S et al (2008) Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery. Singap Med J 49:904–911
Solomayer EF, Diel IJ, Meyberg GC et al (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59:271–278
Er O, Frye DK, Kau SW et al (2008) Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy. Cancer J 14:62–68. doi:10.1097/PPO.0b013e3181629a7b
Hoe AL, Royle GT, Taylor I (1991) Breast liver metastases–incidence, diagnosis and outcome. J R Soc Med 84:714–716
Adam R, De Gramont A, Figueras J et al (2012) The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 17:1225–1239. doi:10.1634/theoncologist.2012-0121
Bergenfeldt M, Jensen BV, Skjoldbye B, Nielsen D (2011) Liver resection and local ablation of breast cancer liver metastases–a systematic review. Eur J Surg Oncol 37:549–557. doi:10.1016/j.ejso.2011.04.013
van Persijn, van Meerten EL, Gelderblom H, Bloem JL (2010) RECIST revised: implications for the radiologist: a review article on the modified RECIST guideline. Eur Radiol 20:1456–1467. doi:10.1007/s00330-009-1685-y
Ahmed M, Solbiati L, Brace CL et al for the International Working Group on image-guided tumor ablation; Interventional Oncology Sans Frontières Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria: a 10-year update. Radiology 273:241–260. doi:10.1148/radiol.14132958
Kennecke H, Yerushalmi R, Woods R et al (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28:3271–3277. doi:10.1200/JCO.2009.25.9820
Mosconi P, Colozza M, De Laurentiis M et al (2001) Survival, quality of life and breast cancer. Ann Oncol 12(Suppl 3):S15–S19
Stockler M, Wilcken NR, Ghersi D, Simes RJ (2000) Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 26:151–168. doi:10.1053/ctrv.1999.0161
Largillier R, Ferrero JM, Doyen J et al (2008) Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol 19:2012–2019. doi:10.1093/annonc/mdn424
Pentheroudakis G, Fountzilas G, Bafaloukos D et al (2006) Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Breast Cancer Res Treat 97:237–244. doi:10.1007/s10549-005-9117-4
Khanfir A, Lahiani F, Bouzguenda R et al (2013) Prognostic factors and survival in metastatic breast cancer: a single institution experience. Rep Pract Oncol Radiother 18:127–132. doi:10.1016/j.rpor.2013.01.001
Sorensen SM, Mortensen FV, Nielsen DT (2007) Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 48:253–258. doi:10.1080/02841850601161539
Vigano L, Ferrero A, Lo Tesoriere R, Capussotti L (2008) Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 15:2458–2464. doi:10.1245/s10434-008-9935-9
Berber E, Ari E, Herceg N, Siperstein A (2005) Laparoscopic radiofrequency thermal ablation for unusual hepatic tumors: operative indications and outcomes. Surg Endosc 19:1613–1617. doi:10.1007/s00464-005-0236-0
Jakobs TF, Hoffmann RT, Schrader A et al (2009) CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. Cardiovasc Interv Radiol 32:38–46. doi:10.1007/s00270-008-9384-7
Mack MG, Straub R, Eichler K et al (2004) Breast cancer metastases in liver: laser-induced interstitial thermotherapy–local tumor control rate and survival data. Radiology 233:400–409. doi:10.1148/radiol.2332030454
Meloni MF, Andreano A, Laeseke PF et al (2009) Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation–intermediate and long-term survival rates. Radiology 253:861–869. doi:10.1148/radiol.2533081968
Sofocleous CT, Nascimento RG, Gonen M et al (2007) Radiofrequency ablation in the management of liver metastases from breast cancer. AJR Am J Roentgenol 189:883–889. doi:10.2214/AJR.07.2198
Tasci Y, Aksoy E, Taskin HE et al (2013) A comparison of laparoscopic radiofrequency ablation versus systemic therapy alone in the treatment of breast cancer metastasis to the liver. HPB (Oxford) 15:789–793. doi:10.1111/hpb.12133
Minami Y, Kudo M (2013) Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver 7:1–6. doi:10.5009/gnl.2013.7.1.1
Conflict of interest
All authors declare no conflict of interests and no funding.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kümler, I., Parner, V.K., Tuxen, M.K. et al. Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer. Radiol med 120, 536–541 (2015). https://doi.org/10.1007/s11547-014-0489-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-014-0489-6